Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
about
Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary systemHigh expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cellsDifferential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer riskCharacterization of the aldo-keto reductase 1C gene cluster on pig chromosome 10: possible associations with reproductive traits.Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breastElevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer.Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells.Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis.Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines.Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patientsNipple Aspirate Fluid Hormone Concentrations and Breast Cancer RiskDeconvoluting complex tissues for expression quantitative trait locus-based analyses.Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.Effects of combined progesterone and 17β-estradiol treatment on the transcriptome of cultured human myometrial smooth muscle cells.Transcript level of AKR1C3 is down-regulated in gastric cancer.Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer.The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells.Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells.N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.Modification of progesterone and testosterone by a food-borne thermophile Geobacillus kaustophilus.Opinion of the Scientific Panel on contaminants in the food chain (CONTAM) related to hormone residues in bovine meat and meat productsIncreased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.
P2860
Q24328776-22419F7D-7455-44A2-8176-AF4062EEBD06Q29249058-AAAED8E8-FC19-402A-8BB0-EE0C028C78CDQ30478225-D5E7AFC7-04C4-4F44-8FC1-2A9306F21F91Q30491822-925F0D50-D745-4F06-940E-0944566A5B70Q33257472-B7D8BA2F-D292-4331-9D6D-162FEB3001FBQ33604649-52EDEE26-2BBF-4F3D-A73A-0553BFAAFA74Q33753945-182E4AA5-4BF8-4A26-8E8B-B30301810B4AQ33763973-96EAC0EC-C115-4D23-B36C-72F0AEDA681DQ33770742-7546D5E0-141F-4FF4-B251-A1BE43BC4BDFQ34007469-623B8487-30D9-4D37-88E5-60F30F9ABC19Q34301072-EE13AEA5-80EE-4DF7-B6E0-AD2C65B4F55EQ34382405-CEFE6506-315A-487C-B76B-FC0F91BC6311Q35721207-10DA12DF-7925-4F53-B15E-359FE77AC60FQ35795746-3F2E359B-76FE-4F19-B120-40428DC52F28Q36003283-8CF3EA2D-E3BD-4D2A-89FE-F3CF27B79E30Q36154045-C0284AB9-5D9C-49E9-8223-554F7C393230Q36728342-14375B56-FEB5-4821-AEC3-3E9B23A673E6Q36929492-D7779A55-D89C-4496-B2ED-A18E5236868EQ36998266-ED0DF330-BA6C-49D4-806B-0076020A3C18Q37277775-396603C8-9C22-4BD1-AA9F-50678757971EQ37698258-69B92F67-286F-45C7-8A6E-26F7B6C6CED6Q38455335-FCEE0706-E6F9-4DF0-9F58-C9B9BB485F68Q38782882-7A4C91C1-AE6B-47D9-96E4-125B526C02FBQ39177408-AE148C91-59CF-480F-8C15-7133E5D6FEC1Q39417854-57DBF8F0-5213-4E49-845C-69FDD8D0832EQ39540562-5F4D6995-5EFB-47BB-A410-50109EFA429EQ39669089-2C131763-DAC1-42B9-8928-77E9850CCA1BQ39810159-DACE2B61-09CA-45C6-8761-7E882924DAD5Q40060405-AAC9CF66-86C3-4469-8EB0-97C4947F81D5Q41949320-04253C60-69E1-4E32-9838-9382558E5893Q43229781-8C03EE0E-4CA4-43A6-A1DC-C34BEF6CA0A4Q47144869-AAD118D9-B602-406C-BBED-38CA427327F1Q51437937-957B4FB6-2D7C-4244-8295-A3B2E85953F3Q53275913-8A230A9C-71BD-4995-A479-C5AA729A1C9D
P2860
Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression of progesterone met ...... ered in human breast carcinoma
@ast
Expression of progesterone met ...... ered in human breast carcinoma
@en
Expression of progesterone met ...... ered in human breast carcinoma
@nl
type
label
Expression of progesterone met ...... ered in human breast carcinoma
@ast
Expression of progesterone met ...... ered in human breast carcinoma
@en
Expression of progesterone met ...... ered in human breast carcinoma
@nl
prefLabel
Expression of progesterone met ...... ered in human breast carcinoma
@ast
Expression of progesterone met ...... ered in human breast carcinoma
@en
Expression of progesterone met ...... ered in human breast carcinoma
@nl
P2093
P2860
P3181
P356
P1433
P1476
Expression of progesterone met ...... ered in human breast carcinoma
@en
P2093
J Godfrey Heathcote
John P Wiebe
Michael J Lewis
P2860
P2888
P3181
P356
10.1186/1471-2407-4-27
P407
P577
2004-06-22T00:00:00Z
P5875
P6179
1012293961